New Key Statistics Module, Z-Score and F-Score
NAS:RSLS Key Ratios
| Market Cap $ M | 4.41 |
| Enterprise Value $ M | 2.08 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.99 |
| Price/Sales | 0.12 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 8.00 |
| EPS (TTM) $ | -2.26 |
| Beneish M-Score | -1.26 |
| 10-y EBITDA Growth Rate % | 37.00 |
| 5-y EBITDA Growth Rate % | 65.60 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -0.19 |
| EV-to-EBITDA | -0.19 |
| PEG | -- |
| Shares Outstanding M | 23.46 |
| Net Margin (%) | -130.99 |
| Operating Margin % | -134.58 |
| Pre-tax Margin (%) | -130.37 |
| Quick Ratio | 1.26 |
| Current Ratio | 2.24 |
| ROA % (ttm) | -99.39 |
| ROE % (ttm) | -189.71 |
| ROIC % (ttm) | -359.31 |
| Dividend Yield % | -- |
| Altman Z-Score | -110.50 |
RSLS Number of Guru Trades
RSLS Volume of Guru Trades
Gurus Latest Trades with NAS:RSLS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:RSLS is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Reshape Lifesciences Inc Insider Transactions
No Available Data
News about NAS:RSLS
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers